Jingjing is an accomplished life sciences leader with a strong biotechnology background and venture capital experience at TVM Capital. She brings deep expertise in business development across biotech and pharma, with a particular focus on cross-border innovation and strategic partnerships between China and Europe. She is fully bilingual in Chinese and English. She holds a Master’s in Biotechnology from Hong Kong University of Science and Technology and an MBA (with M&A specialization) from HEC Paris, and was selected for Danaher’s prestigious General Management Development Program. With her scientific background, investment experience, and global BD expertise, Jingjing has the experience and skills to drive high-impact international partnerships for Antabio.
